AstraZeneca's Rare Drug Trial Failure Sends Shares Plunging
AstraZeneca Plc's shares dropped more than 10% after a trial of a new heart drug failed to help prevent heart problems in patients with a rare disease. Bloom...
Updated 1 min ago · 7 articles from Bloomberg Markets
AstraZeneca Plc's shares dropped more than 10% after a trial of a new heart drug failed to help prevent heart problems in patients with a rare disease. Bloom...
Hilary Knight is at the height of her ice hockey career, but that doesn't mean she's not already thinking about what she'll do with her time in retirement. O...
UIS initial jobless claims decreased by 2,000 to 215,000 in the week ended July 4, a period that included the Independence Day holiday. The median forecast i...
Keiko Fujimori podría ser el tipo de líder que Donald Trump desea en América Latina. Pero los profundos vínculos de Perú con China muestran lo difícil que se...
Gold found some support following three days of losses as traders weighed a resumption of fighting in the Middle East and the US Federal Reserve’s interest-r...
DuPont Registry Group, a luxury car marketplace and media company, has picked banks for a US initial public offering, according to people familiar with the m...
Ed Zitron, CEO at EZ Primary Research, said that the risk of balancing the equity market on record public offerings for AI companies that have never reported...